Another study examined the anti-tumorigenic effects of inulanolide A in prostate cancer, showing its ability to inhibit migration, invasion, and proliferation of prostate cancer cells, regardless of androgen receptor (AR) responsiveness and p53 status. The gene discussed is TP53; the disease is prostate carcinoma.